Efficacy of high-intensity laser therapy versus ultrasound therapy in patients with knee osteoarthritis: a randomized controlled trial
5
item.page.dc.date.issued
2026-12-01
item.page.dc.type
item.page.dc.identifier.issn
02688921
item.page.dc.identifier.eissn
1435604X
item.page.dc.identifier.doi
item.page.dc.identifier.scopus
2-s2.0-105049625368
item.page.dc.identifier.pmid
42709245
item.page.oaire.citation.title
Lasers in Medical Science
item.page.oaire.citation.volume
41
item.page.oaire.citation.issue
1
item.page.dc.rights.holder
SCOPUS
item.page.dc.identifier.citation
Lasers in Medical Science Vol.41 No.1 (2026)
punsarn.item.page.citation
Ninlerd C., Benjakulsap N., Amornsupak C., Phuangphay G., Narkbunnam R., Khomawut N. Efficacy of high-intensity laser therapy versus ultrasound therapy in patients with knee osteoarthritis: a randomized controlled trial. Lasers in Medical Science Vol.41 No.1 (2026). doi:10.1007/s10103-026-05019-8 Retrieved from: https://repository.li.mahidol.ac.th/handle/123456789/118554
item.page.dc.title
Efficacy of high-intensity laser therapy versus ultrasound therapy in patients with knee osteoarthritis: a randomized controlled trial
item.page.dc.contributor.author
item.page.oairecerif.author.affiliation
item.page.dc.contributor.correspondence
item.page.dc.contributor.other
item.page.dc.description.abstract
Purpose: High-intensity laser therapy (HILT) and ultrasound (US) are widely used for knee osteoarthritis (KOA), but comparative efficacy data remain scarce. This study compared HILT and US as exercise adjuncts in patients with KOA. Methods: In this single-center, assessor-blinded RCT, 66 adults with KOA were randomized 1:1 to HILT or US twice weekly for 6 weeks as exercise adjuncts. The primary outcome was WOMAC total score change from baseline to 12 weeks post-treatment (minimum important change [MIC] = 10 points, applied as an approximation). Secondary outcomes included VAS, OKS, KOOS, and EQ-5D-5L. Results: In ITT analysis (N = 66), the HILT group achieved a mean WOMAC reduction of 40.0 vs 8.2 points (adjusted between-group difference: -27.7 points, 95% CI: − 39.0 to − 16.5; p < 0.001, partial η<sup>2</sup> = 0.277). At 12 weeks post-treatment, greater improvements across all secondary outcomes were observed in exploratory analyses (p ≤ 0.012). Furthermore, HILT maintained therapeutic effects up to 12 weeks post-treatment, whereas the US group experienced a gradual loss of post-treatment gains. Conclusion: HILT combined with exercise produced greater short-term improvements in WOMAC total score than US in patients with KOA, with exploratory findings suggesting consistent benefits in pain, function, and quality of life, and with benefits maintained up to 12 weeks after the last treatment session.
